Drug Profile
Amlodipine/Indapamide - Serdia Pharmaceuticals
Alternative Names: NatrilamLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Serdia Pharmaceuticals
- Class Antihypertensives; Dihydropyridines; Indoles; Small molecules; Sulfonamides
- Mechanism of Action Calcium channel antagonists; Thiazide-like diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypertension
Most Recent Events
- 27 Jun 2019 Chemical structure information added
- 25 Dec 2010 Serdia Pharmaceuticals completes a phase III trial in Hypertension in India